Authors

1. Withycombe , Janice S.
2. Kubaney , Holly R.
3. Okada , Maki
4. Yun , Christine S.
5. Gupta , Sumit
6. Bloom , Caylie
7. Parker , Veronica
8. Rau , Rachel E.
9. Zupanec , Sue

Abstract

This study describes current institutional practices surrounding administration of 28-day blinatumomab infusions in children with leukemia and offers a starting point for institutional benchmarking and standardization of practice.